Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Puig, Noemi
- Flores-Montero, Juan
- Burgos, Leire
- Cedena, Maria-Teresa
- Perez, Jose-Juan
- Sanoja-Flores, Luzalba
- Manrique, Irene
- Rodriguez-Otero, Paula
- Rosinol, Laura
- Martinez-Lopez, Joaquin
- Mateos, Maria-Victoria
- Lahuerta, Juan-Jose
- Blade, Joan
- San Miguel, Jesus F
- Orfao, Alberto
- Paiva, Bruno
Grupos
Abstract
Whereas, in most patients with multiple myeloma (MM), achieving undetectable MRD anticipates a favorable outcome, some others relapse shortly afterwards. Although one obvious explanation for this inconsistency is the use of nonrepresentative marrow samples due to hemodilution, there is no guidance on how to evaluate this issue.
Datos de la publicación
- ISSN/ISSNe:
- 2072-6694, 2072-6694
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 34638406
- Factor de Impacto:
- 1,349 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Cancers MDPI
Citas Recibidas en Web of Science: 20
Documentos
- No hay documentos
Filiaciones
Keywords
- hemodilution, minimal residual disease, multiple myeloma
Portal de investigación